Postes actifs de Ram Kamineni
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KRYSTAL BIOTECH, INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 | - |
Historique de carrière de Ram Kamineni
Anciens postes connus de Ram Kamineni
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
KVK-Tech, Inc.
 KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Directeur des opérations | 01/04/2021 | 01/10/2021 |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Health Technology |
- Bourse
- Insiders
- Ram Kamineni
- Expérience